Tags

Type your tag names separated by a space and hit enter

[Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina].
Medicina (B Aires). 2020; 80 Suppl 3:65-66.M

Abstract

Although the incidence is uncertain, some case reports suggest that COVID 19 infection is associated with an increased risk of venous thromboembolism. We suggest starting prophylactic anticoagulant therapy for all patients hospitalized with a symptomatic infection with COVID-19, unless contraindicated, with enoxaparin 40 mg SC daily if creatinine clearance is greater than 30 ml/min.

Authors+Show Affiliations

Servicio de Clínica Médica, Hospital Italiano de Buenos Aires, Argentina.Hematología, Sanatorio Los Arcos, Buenos Aires, Argentina.Departamento de Medicina Interna, Fundación Favaloro, Buenos Aires, Argentina.Departamento de Medicina Interna, FLENI, Buenos Aires, Argentina.Servicio de Clínica Médica, Hospital Italiano de Buenos Aires, Argentina.Clínica Médica, Sanatorio Las Lomas, San Isidro, Argentina.Clínica Médica, Hospital Italiano de Mendoza, Provincia de Mendoza, Argentina.Departamento Materno Infantil, Hospital Juan A. Fernández, Buenos Aires, Argentina.Sección Hematología, Servicio de Clínica Médica del Hospital Italiano de Buenos Aires, Argentina.División Obstetricia, Hospital Juan A. Fernández, Buenos Aires, Argentina.Hospital Español de Rosario, Santa Fe, Argentina.Servicio de Medicina Vascular y Trombosis, Hospital Privado Universitario de Córdoba, Provincia de Córdoba, Argentina.Medicina Interna y Terapia Intensiva, Instituto FLENI, Buenos Aires, Argentina.Sección de Oncología Ginecológica, Servicio de Ginecología, Hospital Italiano de Buenos Aires, Argentina.Servicio de Cirugía General, Hospital Italiano de Buenos Aires, Argentina.Servicio de Clínica Médica, Sanatorio Franchin, Buenos Aires, Argentina.Servicio de Hematología, Hospital Español de Mendoza, Provincia de Mendoza, Argentina.Clínica Médica, Sanatorio Santa Isabel, Buenos Aires, Argentina.Hematología y Hemoterapia, Clínica 25 de Mayo, Mar del Plata, Provincia de Buenos Aires, Argentina.Servicio de Ginecología, Sección Oncológica, Hospital Italiano de Buenos Aires, Argentina.Hospital Español de Rosario, Santa Fe, Argentina.Servicio de Clínica Médica, Hospital Privado de la Comunidad, Mar del Plata, Argentina. E-mail: gandara.esteban@gmail.com.

Pub Type(s)

Case Reports
Journal Article

Language

spa

PubMed ID

32658849

Citation

Vazquez, Fernando J., et al. "[Recommendations for the Use of Thromboprophylaxis in Hospitalized Patients With COVID-19 in Argentina]." Medicina, vol. 80 Suppl 3, 2020, pp. 65-66.
Vazquez FJ, Korin J, Baldessari EM, et al. [Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina]. Medicina (B Aires). 2020;80 Suppl 3:65-66.
Vazquez, F. J., Korin, J., Baldessari, E. M., Capparelli, F. J., Gutierrez, P., Pale, C., Bocanegra, F., Grand, B., Penchasky, D., Gonzalez Alcántara, M. M., Prémoli, M. S., Tabares, A., Wainsztein, N., Odetto, D., Vaccaro, C., Martínez Aquino, E., Cumpian, O., Falabella, V., Antuel García, S., ... Gándara, E. (2020). [Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina]. Medicina, 80 Suppl 3, 65-66.
Vazquez FJ, et al. [Recommendations for the Use of Thromboprophylaxis in Hospitalized Patients With COVID-19 in Argentina]. Medicina (B Aires). 2020;80 Suppl 3:65-66. PubMed PMID: 32658849.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina]. AU - Vazquez,Fernando J, AU - Korin,Jorge, AU - Baldessari,Enrique M, AU - Capparelli,Federico J, AU - Gutierrez,Paula, AU - Pale,Carlos, AU - Bocanegra,Florencia, AU - Grand,Beatriz, AU - Penchasky,Diana, AU - Gonzalez Alcántara,María Mónica, AU - Prémoli,María Sol, AU - Tabares,Aldo, AU - Wainsztein,Néstor, AU - Odetto,Diego, AU - Vaccaro,Carlos, AU - Martínez Aquino,Eleno, AU - Cumpian,Olga, AU - Falabella,Verónica, AU - Antuel García,Santiago, AU - Saadi,José, AU - Siccardi,Mariana, AU - Gándara,Esteban, PY - 2020/7/14/entrez PY - 2020/7/14/pubmed PY - 2020/8/8/medline KW - COVID-19 KW - anticoagulant drugs KW - heparin KW - prophylaxis KW - pulmonary embolism KW - venous thrombosis SP - 65 EP - 66 JF - Medicina JO - Medicina (B Aires) VL - 80 Suppl 3 N2 - Although the incidence is uncertain, some case reports suggest that COVID 19 infection is associated with an increased risk of venous thromboembolism. We suggest starting prophylactic anticoagulant therapy for all patients hospitalized with a symptomatic infection with COVID-19, unless contraindicated, with enoxaparin 40 mg SC daily if creatinine clearance is greater than 30 ml/min. SN - 1669-9106 UR - https://www.unboundmedicine.com/medline/citation/32658849/[Recommendations_for_the_use_of_thromboprophylaxis_in_hospitalized_patients_with_COVID_19_in_Argentina]_ L2 - http://www.medicinabuenosaires.com/PMID/32658849.pdf DB - PRIME DP - Unbound Medicine ER -